Label

How We Work

Grant

Back

Print

GlaxoSmithKline Biologicals


October 2014
to accelerate Ebola Vaccine Production and Development order to treat those affected by the Ebola epidemic in West Africa
$1,281,469
26
Emergency Response
Global Development
Rixensart, Antwerp
https://www.gsk.com/

Visit Our Blog